Anti-C2-mediated complement inhibition prevents disease in a rat passive transfer model of myasthenia gravis
{{output}}
Acetylcholine receptor antibody-positive myasthenia gravis (AChR-MG) is a rare autoimmune disease in which AChR autoantibodies trigger complement activation and cause damage to the neuromuscular junction. This study evaluated the therapeutic potential of an an... ...
